SCHEMBL20528738

SCHEMBL20528738

O=c1oc(-c2ccccc2F)nc2ccc(Br)cc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1R P00736 7/20 0.70
APEX1 P27695 1/20 0.61
F10 P00742 2/20 0.59
F7 P08709 2/20 0.59
F3 P13726 2/20 0.59
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57
CYP1A2 P05177 1/20 0.57
HPGD P15428 1/20 0.57
CYP2C19 P33261 1/20 0.57
F2 P00734 1/20 0.53
ELANE P08246 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
MAPT P10636 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792078 0.85 KMT2A (0.53) C1RAPEX1F10F7F3
SCHEMBL915972 0.84 C1R (0.72) C1RAPEX1F10F7F3
SCHEMBL5793015 0.84 KMT2A (0.63) C1RF7F3KMT2AMEN1
SCHEMBL915773 0.83 C1R (0.73) C1RAPEX1F10F7F3
SCHEMBL30884604 0.83 C1R (1.00) C1RAPEX1F10F7F3
SCHEMBL915734 0.83 C1R (1.00) C1RAPEX1F10F7F3
SCHEMBL914467 0.82 C1R (0.67) C1RAPEX1F10F7F3
SCHEMBL2843939 0.81 NPC1 (0.70) C1RKMT2AMEN1KDM4EALDH1A1
SCHEMBL5790698 0.81 C1R (0.72) C1RKMT2AMEN1KDM4EALDH1A1
SCHEMBL914361 0.81 C1R (0.74) C1RAPEX1F10F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11186571-B2 Quinazolinone derivatives useful for imaging LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2021-11-30 US disclosed
US-20200031821-A1 QUINAZOLINONE DERIVATIVES USEFUL FOR IMAGING LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2020-01-30 US disclosed
WO-2018184115-A1 QUINAZOLINONE DERIVATIVES USEFUL FOR IMAGING LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2018-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031821-A1 QUINAZOLINONE DERIVATIVES USEFUL FOR IMAGING TNNI3, KLK3, BRDT C1R 1731/4885APEX1 1745/4885F10 2268/4885
US-11186571-B2 Quinazolinone derivatives useful for imaging TNNI3, KLK3, BRDT C1R 1731/4885APEX1 1745/4885F10 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.